Results of non-invasive prenatal testing compare well to those from invasive methods, with better safety and cost

A new noninvasive fetal sequencing (NIFS) technology can simultaneously screen nearly 23,000 genes while matching invasive testing accuracy, offering safer and more cost-effective prenatal diagnostics than current methods.

This does not prove the technology is ready for clinical use—it is being presented at a conference and would still require regulatory approval, clinical validation, and real-world implementation before widespread adoption.